Your browser doesn't support javascript.
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.
Abolhassani, Hassan; Landegren, Nils; Bastard, Paul; Materna, Marie; Modaresi, Mohammadreza; Du, Likun; Aranda-Guillén, Maribel; Sardh, Fabian; Zuo, Fanglei; Zhang, Peng; Marcotte, Harold; Marr, Nico; Khan, Taushif; Ata, Manar; Al-Ali, Fatima; Pescarmona, Remi; Belot, Alexandre; Béziat, Vivien; Zhang, Qian; Casanova, Jean-Laurent; Kämpe, Olle; Zhang, Shen-Ying; Hammarström, Lennart; Pan-Hammarström, Qiang.
  • Abolhassani H; Department of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge Stockholm, Sweden.
  • Landegren N; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Bastard P; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Materna M; Centre for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Modaresi M; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
  • Du L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de La Santé Et de La Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.
  • Aranda-Guillén M; University of Paris, Imagine Institute, Paris, France.
  • Sardh F; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de La Santé Et de La Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.
  • Zuo F; University of Paris, Imagine Institute, Paris, France.
  • Zhang P; Division of Pediatrics Pulmonary Disease, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
  • Marcotte H; Department of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge Stockholm, Sweden.
  • Marr N; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Khan T; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Ata M; Centre for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Al-Ali F; Department of Biosciences and Nutrition, Karolinska Institutet, 14183, Huddinge Stockholm, Sweden.
  • Pescarmona R; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
  • Belot A; Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Béziat V; Department of Human Immunology, Sidra Medicine, Doha, Qatar.
  • Zhang Q; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
  • Casanova JL; Department of Human Immunology, Sidra Medicine, Doha, Qatar.
  • Kämpe O; Department of Human Immunology, Sidra Medicine, Doha, Qatar.
  • Zhang SY; Department of Human Immunology, Sidra Medicine, Doha, Qatar.
  • Hammarström L; Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard, Lyon 1, Centre National de La Recherche Scientifique, UMR5308, ENS de Lyon, Lyon, France.
  • Pan-Hammarström Q; Laboratoire d'immunologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
J Clin Immunol ; 42(3): 471-483, 2022 04.
Article in English | MEDLINE | ID: covidwho-1653615
ABSTRACT

BACKGROUND:

Inborn errors of immunity (IEI) and autoantibodies to type I interferons (IFNs) underlie critical COVID-19 pneumonia in at least 15% of the patients, while the causes of multisystem inflammatory syndrome in children (MIS-C) remain elusive.

OBJECTIVES:

To detect causal genetic variants in very rare cases with concomitant critical COVID-19 pneumonia and MIS-C.

METHODS:

Whole exome sequencing was performed, and the impact of candidate gene variants was investigated. Plasma levels of cytokines, specific antibodies against the virus, and autoantibodies against type I IFNs were also measured.

RESULTS:

We report a 3-year-old child who died on day 56 of SARS-CoV-2 infection with an unusual clinical presentation, combining both critical COVID-19 pneumonia and MIS-C. We identified a large, homozygous loss-of-function deletion in IFNAR1, underlying autosomal recessive IFNAR1 deficiency.

CONCLUSIONS:

Our findings confirm that impaired type I IFN immunity can underlie critical COVID-19 pneumonia, while suggesting that it can also unexpectedly underlie concomitant MIS-C. Our report further raises the possibility that inherited or acquired dysregulation of type I IFN immunity might contribute to MIS-C in other patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid / Variants Limits: Child, preschool / Humans Language: English Journal: J Clin Immunol Year: 2022 Document Type: Article Affiliation country: S10875-022-01215-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid / Variants Limits: Child, preschool / Humans Language: English Journal: J Clin Immunol Year: 2022 Document Type: Article Affiliation country: S10875-022-01215-7